查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1392006

CRISPR 基因組治療市場：依產品類型、應用、最終用戶、地區

CRISPR Genomic Cure Market, By Product Type, By Application, By End User (Biopharmaceutical Companies, Contract Research Organizations, Genetic Research Laboratories, Others), By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球 CRISPR 基因組療法市場規模預計將從 2023 年的 31.8 億美元增至 2030 年的 117.1 億美元，預測期內複合年成長率為 20.5%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 31.8億美元
實績資料 2018-2021 預測期 2023-2030
預測期複合年成長率 20.50% 2030年市場規模預測 117.1億美元
圖 1. 2023 年依地區分類的 CRISPR 基因組療法的全球市場佔有率(%)
CRISPR基因組治癒市場-IMG1

全球 CRISPR 基因組治療市場是全球生物技術產業中快速發展的區隔市場。 CRISPR（成簇規則間隔短回文重複序列）是一項突破性的基因編輯技術，可對基因組 DNA 進行定向的改變。這項技術有可能徹底改變多種疾病的治療，包括遺傳疾病、癌症和感染疾病。 CRISPR 基因組療法市場是由遺傳性疾病日益流行以及對有效治療方法的需求不斷成長所推動的。該技術能夠以前所未有的精確度修改基因，為治療以前認為無法治療的疾病提供了新的可能性。此外，CRISPR技術的進步，例如開發更有效率、更安全的基因編輯工具，預計將進一步推動該市場的成長。增加研發活動投資以及擴大生物技術公司和研究機構之間的合作也有助於擴大全球 CRISPR 基因組治療市場。然而，該市場面臨一些課題，包括與基因編輯相關的倫理和安全問題、監管障礙以及基於 CRISPR 的治療方法的開發和商業化的高成本。儘管存在這些課題，在該技術徹底改變醫療保健的巨大潛力的推動下，全球 CRISPR 基因組治療市場預計在未來幾年將顯著成長。總之，全球 CRISPR 基因組治療市場是一個充滿前景且充滿活力的市場，有潛力為各種疾病的治療帶來重大進展。

市場動態：

慢性病、遺傳疾病、感染疾病、血液系統疾病、代謝性疾病的盛行率不斷上升，老年人口不斷增加，對安全有效的治療和療法、細胞和基因療法的需求不斷增加基因療法的資金增加，基因療法的頻繁核准、新療法的推出以及人們對全球 CRISPR 基因組治療市場的認知不斷提高是預計在預測期內促進全球 CRISPR 基因組治療市場成長的關鍵因素。

例如，2021年3月，來自加州大學舊金山分校、加州大學柏克萊分校和加州大學洛杉磯分校（UCLA）的科學家啟動了一項針對鐮狀病患者的CRISPR基因修飾療法的初步研究，使用患者自身的造血幹細胞獲得美國食品藥物管理局（FDA）核准，共同開始階段人體臨床試驗。與目前健康骨髓捐贈者幹細胞移植的治療治療方法相比，這種治療方法有可能徹底改變鐮狀細胞疾病的治療方法，創造出一種更安全、更容易獲得和更有效的治療方法。此外，這種治療方法還可以預防鐮狀細胞疾病的不可逆併發症。

本研究的主要特點

  • 本報告對全球CRISPR基因組治療市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023-2030）的市場規模和復合年成長率。
  • 該報告還闡明了各個區隔市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
  • 該報告還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 該報告根據以下參數（例如公司亮點、產品系列、主要亮點、績效和策略）介紹了全球 CRISPR 基因組治療市場的主要企業。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出資訊的決策。
  • 全球 CRISPR 基因組治療市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球 CRISPR 基因組治療市場的各種策略矩陣來促進他們的決策。

第1章 研究目的與假設

  • 研究目標
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章市場動態、法規及趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第4章全球 CRISPR 基因組治療市場 – 冠狀冠狀病毒(COVID-19) 大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第5章全球 CRISPR 基因組治療市場，依產品類型，2018-2030

  • 介紹
  • 套件和試劑
  • 圖書館
  • 向量設計
  • 檢測設計
  • 其他

第6章 2018-2030 年全球 CRISPR 基因組治療市場（依應用）

  • 介紹
  • 腫瘤學
  • 遺傳疾病
  • 基因組工程
  • 其他

第 7 章 2018-2030 年全球 CRISPR 基因組治療市場（依最終用戶）

  • 介紹
  • 生物製藥公司
  • 受託研究機構（CRO）
  • 基因研究
  • 其他

第8章2018-2030年全球CRISPR基因組治療市場（依地區）

  • 介紹
  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 義大利
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 印度
  • 中國
  • 日本
  • 澳洲
  • 韓國
  • 東南亞國協
  • 亞太地區其他地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第9章競爭形勢

  • Merck KgaA
  • Thermo Fisher Scientific Inc.
  • Origene Technologies, Inc.
  • New England Biolabs
  • Intellia Therapeutics, Inc.
  • GenScript
  • GeneCopoeia, Inc.
  • Cellectis
  • Mammoth Biosciences
  • Precision Biosciences, Inc.
  • Synthego Corporation
  • CRISPR Therapeutics
  • Horizon Discovery Group plc
  • Lonza Group Ltd.
  • Takara Bio Inc.

第10章

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI5856

The global CRISPR genomic cure market size is expected to reach US$ 11.71 Bn by 2030, from US$ 3.18 Bn in 2023, at a CAGR of 20.5% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 3.18 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 20.50% 2030 Value Projection: US$ 11.71 Bn
Figure 1. Global CRISPR Genomic Cure Market Share (%), by Region, 2023
CRISPR Genomic Cure Market - IMG1

The global CRISPR genomic cure market is a rapidly evolving sector within the global biotechnology industry. CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. This technology has the potential to transform the treatment of a wide range of diseases, including genetic disorders, cancers, and infectious diseases. The market for CRISPR genomic cures is driven by the increasing prevalence of genetic diseases and the growing demand for effective therapies. The technology's ability to modify genes with unprecedented precision has opened up new possibilities for the treatment of diseases that were previously considered untreatable. Moreover, advancements in CRISPR technology, such as the development of more efficient and safer gene-editing tools, are expected to further propel the growth of this market. The increasing investment in research and development activities, coupled with the growing collaboration between biotechnology companies and research institutes, is also contributing to the expansion of the global CRISPR genomic cure market. However, the market faces several challenges, including ethical and safety concerns related to gene editing, regulatory hurdles, and the high cost of developing and commercializing CRISPR-based therapies. Despite these challenges, the global CRISPR genomic cure market is expected to witness significant growth in the coming years, driven by the technology's immense potential to revolutionize healthcare. In conclusion, the global CRISPR genomic cure market represents a promising and dynamic field with the potential to bring about significant advancements in the treatment of various diseases.

Market Dynamics:

Increasing prevalence of chronic disease, genetic disease, infectious diseases, neurological disease, blood disease, and metabolic disease, a growing geriatric population, growing demand for safe and effective treatment or therapies, increasing funding for cell and gene therapies, frequent approvals for gene therapies, the introduction of novel therapies, and increasing awareness among people about the global CRISPR genomic cure market are major factors expected to augment the growth of the global CRISPR genomic cure market during the forecast period.

For instance, in March 2021, scientists at UC San Francisco, UC Berkeley, and UCLA received U.S. Food and Drug Administration (FDA) approval to jointly launch an early-phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient's own blood-forming stem cells. The therapy has the potential to transform sickle cell disease care by producing an accessible, curative treatment that is safer than the current therapy of stem cell transplant from a healthy bone marrow donor. Moreover, the therapy has the potential to prevent irreversible complications of the disease.

Key features of the study:

  • This report provides in-depth analysis of the global CRISPR genomic cure market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global CRISPR genomic cure market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific Inc., Origene Technologies, Inc., New England Biolabs, Intellia Therapeutics, Inc., GenScript, GeneCopoeia, Inc., Cellectis, Mammoth Biosciences, Precision Biosciences, Inc., Synthego Corporation, CRISPR Therapeutics, Horizon Discovery Group plc, Lonza Group Ltd., Takara Bio Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global CRISPR genomic cure market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global CRISPR genomic cure market

Detailed Segmentation:

  • By Product Type:
    • Kits & Reagents
    • Libraries
    • Vector Design
    • Assay Design
    • Others
  • By Application:
    • Oncology
    • Genetic Diseases
    • Genomic Engineering
    • Others
  • By End User:
    • Biopharmaceutical Companies
    • Contract Research Organizations (CROs)
    • Genetic Research Laboratories
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Origene Technologies, Inc.
    • New England Biolabs
    • Intellia Therapeutics, Inc.
    • GenScript
    • GeneCopoeia, Inc.
    • Cellectis
    • Mammoth Biosciences
    • Precision Biosciences, Inc.
    • Synthego Corporation
    • CRISPR Therapeutics
    • Horizon Discovery Group plc
    • Lonza Group Ltd.
    • Takara Bio Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market CRISPR Genomic Cure Market, By Product Type
    • Market CRISPR Genomic Cure Market, By Application
    • Market CRISPR Genomic Cure Market, By End User
    • Market CRISPR Genomic Cure Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global CRISPR Genomic Cure Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global CRISPR Genomic Cure Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Kits & Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Libraries
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Vector Design
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Assay Design
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global CRISPR Genomic Cure Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Genetic Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Genomic Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global CRISPR Genomic Cure Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Biopharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Genetic Research Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global CRISPR Genomic Cure Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • India
  • China
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of the APAC
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

  • Merck KgaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
  • Origene Technologies, Inc.
  • New England Biolabs
  • Intellia Therapeutics, Inc.
  • GenScript
  • GeneCopoeia, Inc.
  • Cellectis
  • Mammoth Biosciences
  • Precision Biosciences, Inc.
  • Synthego Corporation
  • CRISPR Therapeutics
  • Horizon Discovery Group plc
  • Lonza Group Ltd.
  • Takara Bio Inc.
  • Analyst Views

10. Section

  • Research Methodology
  • About us